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ABSTRACT: The separation of an enantiomer from a
racemic mixture is of primary relevance to the pharmaceutical
industry. The thermochemical properties of organic enantio-
pure and racemate crystals can be exploited to design an
enantioselective crystallization process. The thermodynamic
diﬀerence between the two crystal forms is accessible by two
cycles which give the eutectic composition in solution. The
“sublimation cycle” requires calculating the lattice energy and
phonon frequencies of the crystal structures. Experimental
results from heat capacity and other thermodynamic measure-
ments of enantiopure and racemic crystals are compared with a variety of molecular and crystal structure-based calculations. This
is done for three prototypes of pharmaceutical-like molecules with diﬀerent degrees of molecular ﬂexibility. Diﬀerences in crystal
packing result in varying temperature-dependent heat capacities and aﬀect the sublimation thermodynamics, relative solubility,
and eutectic composition. Many simplifying assumptions about the thermodynamics and solubilities of the racemic and
enantiopure crystals are critically evaluated. We show that calculations and experimental information using the sublimation cycle
can guide the design of processes to resolve enantiomers by crystallization.
1. INTRODUCTION
New pharmaceuticals are predominantly chiral compounds but
often are synthesized as racemates, i.e., an equimolar mixture of
two enantiomers.1 Despite identical chemical structures, the
two mirror images display diﬀerent pharmacological, toxico-
logical, and pharmacokinetic properties. Chiral separation of
these compounds or proof of harmlessness of the inactive
enantiomer is now required for drug product approval2 and is
gaining importance also in the agrochemical sector.3 There are
diﬀerent processes to separate enantiomers, but, if possible,
crystallization is usually the preferred method for manufacture.4
Crystallization-based separation of enantiomers leads to pure
crystalline enantiomers, and recent computational estimates
suggest5 that it may be applicable to more systems if the
molecular basis were fully understood. Such an enantioselective
crystallization process depends on the ternary phase diagram
between crystalline enantiomer, racemate, and solvent when
crystallization is driven by thermodynamic control. The key
parameters to a successful process are the solubilities of the
pure enantiomer and the racemate, the composition of the
eutectic system in the given solvent (mixture), and temper-
ature. The eutectic composition, deﬁned as the maximum
solubility of one enantiomer in the presence of the second (see
Supporting Information, Figure S1), xeu = xS
eu/(xS
eu + xR
eu) can be
a function of temperature, T, and solvent.6,7 In some cases
shifts in the composition at the eutectic (“eutectic shifts”) can
vary suﬃciently with temperature to allow separation by a two-
step crystallization process.7 Polymorphism and the formation
of solvates further complicate advanced process design. In early
stages of drug development, it is desirable to have computa-
tional methods to support, or possibly replace, many
experimental investigations. The diﬀerence in solution free
energies ΔRS−S ΔGsol determines the enantiomeric enrichment.
ΔGsol can, in principle, be obtained from two hypothetical
thermodynamic cycles8,9 (see Figure 1):
(i) transfer of the molecule from crystal to the supercooled
melt and then exchange of molecules between the melt
and solvent, and
(ii) transfer of the molecule from crystal to vapor and then
into solution.
Cycle (i), the “melt cycle”, requires knowledge of the melting
temperature and enthalpy of melting for determining the Gibbs
free energy of melting via ΔGmelt = ΔHmelt − T ΔHmelt/Tmelt
plus thermal contributions of the solid and the supercooled
melt (see Figure 1).
This approach is used by the general solubility equation
(GSE),10−12 other QSPR methods,13 and by activity coeﬃcient
based models.14 Several organic compounds already decompose
before or during melting, which poses a severe restriction on its
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applicability as the melting properties can only be predicted
computationally by group contribution or QSPR methods
which cannot distinguish between polymorphs or chiral
molecules.15,16 The other major term, the partial molar Gibbs
free energy of mixing the solvent with the supercooled melt, is
accessible by correlative activity coeﬃcient and predictive based
models (gE-models)14,17,18 Cycle (ii), the “sublimation cycle”,
the focus of this paper, approximates the solubility diﬀerences
by taking the molecule from the crystal to the gas phase and
then into solution.
Both cycles consider properties from the crystals (melting or
sublimation free energy) and are thus dependent on the crystal
structures of the racemate and enantiomer. The sublimation
cycle is preferred as it makes use of the computationally
accessible thermodynamics states from the gas and the
crystalline solid.
The “sublimation cycle” has been evaluated for the
computational prediction of the solubility19 and sublimation
free energies of organic crystals.20 Here, we evaluate the
sublimation cycle to obtain diﬀerences in solubilities of the
racemic and enantiopure crystals and to assess the relevance of
diﬀerences in thermodynamic terms which are often taken to be
negligible. In the sublimation cycle, the mole fraction solubility,
x, is directly related to the Gibbs free energy of solution21−23
and can be calculated from the sublimation and solvation free
energies (lower part of Figure 1).
− = Δ = Δ + ΔRT x G G Gln sol subl solv (1)
Assuming that there is no polymorphic phase transition
between 0 K and the temperature of interest, T, (e.g., the
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where Elatt is the lattice energy, EZPE is the zero-point
vibrational energy and CP
g−s(T) = CP
g(T) − CPs (T) is the
temperature-dependent isobaric heat capacity diﬀerence
between the gas (g) and solid (s). The term Hcorr is the sum
of the zero-point energies (ZPEs) and the integrals of CP and is
often referred to as the “thermal correction”. Thus, calculations
of the solubility will not only be dependent on the accuracy of
the lattice energy calculations, but also on that of other
contributions to the thermodynamic cycles.19
The molecules investigated in this study (Figure 2) were
chosen to represent prototypes of frequently occurring organic
crystalline compound classes: an almost rigid molecule with no
hydrogen bonding capability (lactide), a drug molecule with
intermediate ﬂexibility but only one hydrogen bonding group
(naproxen), and a molecule with considerable ﬂexibility and
competing hydrogen bond donors close to the chiral center (3-
chloromandelic acid).
The lactide is an internal cyclic ester of lactic acid. Both the
racemic molecular compound and the (S)-enantiomer are used
in the preparation of polylactide,24,25 a biologically decom-
posable polymer with many complex properties that make it
ideal for medical applications.26 Naproxen is marketed in the
enantiopure form as a nonsteroidal anti-inﬂammatory drug,
although the racemic form is more stable.27,28 3-Chloroman-
delic acid (3ClMA) is used as an intermediate for
pharmaceutical products and represents the mandelic acid
family of prototypical chiral molecules.29 It has complex
polymorphic crystallization behavior that deﬁes many current
assumptions.29,30
Temperature-dependent heat capacities for the enantiopure
and racemic crystals were determined experimentally and by
computational methods for these substances. This experimental
comparison is rare, with most examples being zwitterionic
amino acids.31−37 Assuming that the eutectic composition is
under thermodynamic control,6,38,39 we use a variety of
experimental thermodynamic measurements and the “sub-
limation cycle” to evaluate whether current computational
approaches can predict the eutectic composition. We critically
assess the underlying assumptions that are being made to make
the calculations feasible. The dominant contribution of
breaking up the crystal lattice is the lattice energy, Elatt. The
lattice energy has been widely used for understanding and
modeling the organic solid state,40−44 but improvements in
modeling Elatt show that relative ﬁnite temperature thermody-
namic properties, arising from the molecular motion, are
relevant. We are assessing ﬁrst the separated model ψmol for
which molecular vibrations are assumed to be the same in the
gas and both crystals, and so the rigid-body lattice modes can
be used.45,46 This requires electronic structure calculations on
the isolated molecule only, as these can be used to deﬁne an
intermolecular potential for modeling the crystals. The second
recognizes that crystal packing can modify both molecular and
phonon lattice modes.47 Calculating the coupled vibrational
modes is dependent on the potential energy surface for nuclear
Figure 1. Two thermodynamic cycles to obtain the free energy of
solution ΔGsol. The melt cycle relies on the free energy of melting,
ΔGmelt, and on the free energy of mixing ΔGE = RT ln γ. The
sublimation cycle uses the free energies of sublimation ΔGsubl, and the
solvation free energy ΔGsolv. Solvent-dependent properties are in red.
Figure 2. Molecular structures of the three representative chiral
molecules: (left) 3,6-dimethyl-1,4-dioxane-2,5-dione (lactide C6H8O4),
(middle) naproxen C14H14O3, (right) 3-chloromandelic acid (3ClMA,
C8H7O3Cl). The most ﬂexible torsion angles are marked.
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motion within the crystal, and hence the use of periodic
electronic structure calculations ψcrys. Dispersion corrected
density functional methods, which have been widely used for
lattice energies, proved to be too computationally demanding
to obtain converged phonon frequencies across the Brillouin
zone,48,49 so more approximate electronic structure methods
have been used. We critically assess the accuracy of the
underlying assumptions against carefully determined exper-
imental thermodynamic for chiral compounds, rarely available
in early stage drug development. This study indicates that the
combination of computation and experimental data can assist
the design of enantiomeric separation crystallization processes
but also points to the challenges in computational process
design.
2. BASIC THERMODYNAMIC MODELS
In the following we brieﬂy introduce the framework for the
computation of the solid-state thermodynamic quantities and
its application within a thermodynamic model to predict the
eutectic composition of chiral compound-forming systems in
solution.
2.1. The Solution Thermodynamics of Chiral Systems.
The eutectic composition xeu can be estimated as a function of
the solubility ratio between the racemic compound and the
enantiomer α = xRS/xS (see Supporting Information, pp S2−
S4)6 via the diﬀerence in Gibbs free energy of solution between
the racemic compound and the enantiomer, ΔRS‑SΔGsol =
ΔGsol,RS − ΔGsol,S, to give
α
=
+
=
+ − Δ Δ−( )
x
1
1 /4
1
1 1/4 exp 2 G
RT
eu 2
RS S sol
(3)
This derivation diﬀers in the reference state used from a
previously proposed model (see Supporting Information, pp
S4−S5).39,50 The two thermodynamic cycles in Figure 1 can be
used to relate ΔRS‑SΔGsol, and hence the eutectic composition
(eq 3), to either the diﬀerence in free energies of melting,
ΔRS‑SΔGmelt, or the diﬀerence in free energy of sublimation,
ΔRS‑SΔGsubl. Focusing on the sublimation cycle we get a relation
between α and the sublimation thermodynamics (Figure 1, eq
1) by
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In eq 4 several levels of approximations are implicit which
minimize the computational eﬀort to calculate relative
solubilities: (i) the solutions of enantiomer and racemate are
ideal, or so similar that ΔRS‑SΔGsolv = 0, and the solvent is
achiral; (ii) entropy contributions are the same for the
enantiomer and the racemic compound in the solid phase
and the gas; (iii) the thermal correction, Hcorr, (eq 2) is equal
for the enantiomer and the racemic compound or even
molecule independent, as in the frequently used “2RT
approximation”:
Δ = − −H T E RT( ) 2subl latt (5)
This approximation is frequently invoked in the computa-
tional prediction of solubilities51 and sublimation enthalpies of
organic molecules.20 It arises from the equipartition theorem of
internal degrees of freedom for the gas and the crystal,
assuming an ideal gas and the Dulong-Petit model of a perfect
atomic crystal.52 This relationship enables sublimation
enthalpies to be estimated without the need to calculate the
vibrational (phonon) modes of the crystal. However, recently
this approximation has been shown to be poor, with errors up
to 5 kJ mol−1 (Supporting Information, Figure S3) for small
molecular crystals.53−55 However, for comparing the thermody-
namic dif ferences between enantiopure and racemic crystals,
parts of the thermodynamic quantities of Hcorr are likely to
cancel out, with the gas phase contributions to Hcorr (eq 2)
being assumed to be identical for both chiral species.
2.2. Lattice and Zero-Point Energies, Heat Capacities,
and Entropic Contributions. The lattice energy Elatt
characterizes a static perfect inﬁnite crystal and an ideal gas
phase in its lowest energy conformation, both at 0 K. Taking
this as the zero of energy, we can calculate the lattice energy
from periodic electronic structure models, ψcrys. Less computa-
tionally expensive ψmol calculations further separate the lattice
energy into crystal and isolated molecule contributions,
providing a separated model:56
= + ΔE U Elatt inter intra (6)
where ΔEintra is the diﬀerence in energy for a single molecule in
the crystal conformation and in its lowest energy conformation
(ΔEintra = 0 for rigid molecules) and is typically less than a few
kJ·mol−1 unless intramolecular hydrogen bonding is involved.44
Both ψcrys and ψmol models can be used to calculate the lattice
vibrations (phonons) from the second derivatives of the lattice
energy, i.e., within the harmonic approximation. In the ψmol
model, it is assumed that the molecular modes are unaﬀected
by crystal packing and thus can be estimated from the
vibrational frequencies of the isolated molecule and combined
with the rigid-body lattice modes. Our ψmol model is further
simpliﬁed by only using the k = 0 modes of the unit cell,
ignoring the diﬀerence in size and shape between the racemic
and enantiopure crystals. ψcrys generates all the vibrational
modes, including the high frequency molecular modes, and
calculates the heat capacity, zero-point energies and entropy by
integration over the Brillouin zone.45,57,58 Full details of both
computational models are given in Supporting Information, pp
S4−S5. Both methods give EZPE and heat capacities at constant
volume CV. The isobaric and isochoric solid state heat
capacities CP
s and CV
s are related by the bulk modulus, K, and
the thermal volume expansion coeﬃcient αT.
α= +C T C T TVK( ) ( )P Ts Vs 2 (7)
If the thermal expansion of the unit cell is neglected, which is
consistent with making the harmonic approximation, we can
directly compare experimental CP
s (T) with computed CV
s (T).
This approximation is made throughout the paper, but it is
tested for naproxen using quasi-harmonic calculations (see
Supporting Information, p S29−S32).
3. MATERIALS AND METHODS
3.1. Enantiopure and Racemic Compounds and Crystal
Forms. Samples of (S)-lactide, (RS)-lactide, (S)-naproxen, (RS)-
naproxen, (R)-3ClMA, (R,S)-3ClMA, and (R)- and (RS)-mandelic
acid were available commercially and puriﬁed and recrystallized where
needed, and conﬁrmed to correspond to single polymorphs (see
Supporting Information, p S10 for more information).
3.2. Experimental Methods. Heat Capacity Measurements.
Low-temperature heat capacities for enantiopure and racemic
naproxen and 3ClMA crystals were measured by means of direct
heat pulse calorimetry (DHPC) from 2 to 200 K. A commercially
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available relaxation calorimeter has been used at the Institute of
theoretical Physics of the Goethe University in Frankfurt, the physical
property measurement system (PPMS) from Quantum Design. Heat
capacities above room temperature were measured using a DSC 111
calorimeter from Setaram.59 Sapphire and benzoic acid were used as
reference standards. Average deviations to published data were 1.4%
for sapphire60 and 2.6% for benzoic acid.61 Additional diﬀerential
scanning calorimetry (DSC) measurements of the closely related (R)-
and (RS)-mandelic acid molecules were performed between 298 and
370 K using the same measurement method as for the other molecules
(more details can be found in the Supporting Information, p S26).
Solid State Raman Spectra. Solid-state Raman analysis of the
powdered crystals was performed with a commercial MultiRAM
spectrometer from Bruker, Germany. The system employs a laser
beam at 1064 nm and was operated at 500 mW. The analyses were
carried at ambient temperature averaging over 32 scans with a spectral
resolution of 1 cm−1 between 10 and 3500 cm−1.
Eutectic Composition and Thermochemical Properties. Eutectic
compositions in various solvent systems were taken from literature for
lactide62,63 and 3ClMA.30,63 and measured here for (S)- and (RS)-
naproxen (see Supporting Information, Table 28). Additional
solubilities were measured in a variety of solvents for lactide to
supplement previous measurements. Melting properties, vapor
pressures, and corresponding enthalpies and free energies of
sublimation were taken from the literature27,30,64,65 where available
and are summarized in the Supporting Information, Tables S3−S4.
3.3. Computational Methods. Within the electronic (ψcrys)
model we compare thermochemical properties from two approximate
dispersion corrected periodic electronic structure methods based on a
minimal basis set Hartree−Fock (HF-3c)66,67 and on a tight-binding
Hamiltonian (DFTB3-D3).53 HF-3c and DFTB3 calculations were
performed with a developer version of CRYSTAL14,68 and DFTB+,69
respectively. In the separated ψmol model, the isolated molecular
structures were geometry optimized and molecular vibrations in the
rigid rotor harmonic oscillator (RRHO) approximation were
calculated at the PBE/def2-TZVP level of theory using the D3
dispersion correction70 with TURBOMOLE V6.4.71 The rigid-
molecule lattice frequencies were calculated using DMACRYS.56
The lattice energy was determined using CrystalOptimizer72 allowing
the ﬂexible torsion angles in Figure 2 to adapt to the packing forces. In
order to compare experimental and computational enthalpic and
entropic contributions, a combined “exp/theory” method is con-
structed, in which experimental heat capacities are interpolated and
numerically integrated using spline functions within MATLAB
(Mathworks). These can be combined with calculated ideal gas heat
capacities from the isolated molecular frequencies and calculated zero-
point energies from ψmol to give Hcorr and sublimation entropies
according to eq 2. The free energy of solvation, ΔGsolv, was computed
with the thermodynamic model COSMO-RS73 including the distinct
ﬂexibility of the three molecules by a Boltzmann weighting of possible
conformers. For more details see Supporting Information, pp S35−
S36.
4. RESULTS
4.1. Temperature-Dependent Solid State Heat Ca-
pacities. Temperature-dependent heat capacity measurements
for enantiopure and racemic crystalline powders of the three
substances were recorded in temperature ranges from 2 to 202
K and 298 to 410 K (or until melting) and are given in the
Supporting Information, Figures S4−S5, and tabulated in
comparison with the calculated values (Supporting Information,
Tables S13−S22). At very low temperatures the heat capacities
follow Debye’s cubic law (CP ∝ T3), then increase linearly with
temperature and do not level even approaching the highest
temperatures of 400 K. Thus, the assumption of mode
saturation in the 2RT correction (eq 3) is not valid for any
of the organic molecular crystals. Naproxen has a signiﬁcantly
larger heat capacity than 3ClMA and lactide due to the larger
number of atoms per molecule. The results are in agreement
with previous measurements for the lactide64,74 and naproxen75
and within the 1−5% accuracy of DSC76 heat capacity
measurements. The calculated temperature-dependent heat
capacities reproduce the temperature dependence up to 200 K
and also give the diﬀerences in magnitude between the diﬀerent
organic molecules. At higher temperature, the calculations
appear to systematically underestimate heat capacities. which
was also found for many small molecular crystals.48 A
systematic experimental overestimate of high temperature
DSC could be ruled out by comparing to benzoic acid and
sapphire (see Supporting Information, p S12 and S28 for more
information).
4.2. Heat Capacity Diﬀerences between Enantiomeric
and Racemic Crystals. Since we are focusing on the free
energy diﬀerences and relative thermodynamic quantities, heat
capacity diﬀerences between the racemic and enantiopure
substances, ΔRS−SCP(T) = CP,RS − CP,S, are discussed. Below
100 K, the experimental heat capacity diﬀerences are between
−1 and 3 J mol−1 K−1 and distinguishable between the three
molecules (Figure 3), changing in sign between molecules and
with temperature. The naproxen heat capacity diﬀerence for
example changes sign twice, rising between 150 and 200 K. The
heat capacities for naproxen above 150 K have signiﬁcant
experimental error bars due to a loss in thermal coupling as
described by the supplier.77 The calculated heat capacities from
ψcrys only qualitatively reproduce diﬀerences between enan-
tiomer and racemate at the low temperatures, but do show a
marked system dependence. The computed harmonic rigid-
molecule, mode separated ψmol calculations in Figure 3 show an
asymptotic approach to heat capacity diﬀerences of zero for all
compounds.
The heat capacity diﬀerences between the racemic and
enantiopure substances, ΔRS‑SCP(T), at 298 K are summarized
in Table S25 in the Supporting Information. The high
temperature heat capacity diﬀerences in the range of 300−
370 K in Figure 4 are particularly pronounced for 3ClMA,
where the heat capacity of the enantiomer at 298 K is 211.1 ±
1.6 J mol−1 K−1, which is 9.2 ± 2.2 J mol−1 K−1 (4.5%) larger
than that of the racemic crystal (201.9 ± 1.5 J mol−1 K−1; see
Figure 4). Such a signiﬁcant heat capacity diﬀerence had
Figure 3. Low temperature heat capacity diﬀerences, ΔRS‑SCP, between
racemic and enantiopure crystals. Experimental results (dots) are
shown with experimental uncertainty and compared with calculated
ΔRS‑SCV values from electronic ψcrys HF-3c (solid lines) and separated
ψmol (dashed lines) phonon modes.
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previously been reported for mandelic acid31 at temperatures
that are relevant for a crystallization process (5−70 °C), so we
repeated the experiment for (RS)- and (S)-mandelic acid (see
Supporting Information, S23−S24 for primary data) to conﬁrm
the previous results,31 and found that the heat capacity
diﬀerence between the enantiopure and racemic crystals
increases with temperature for mandelic acid but is almost
constant for 3ClMA (Figure 4). At 298 K the lactide shows a
small heat capacity diﬀerence, with that of the (RS)-lactide
being only 0.6 ± 0.5 J·mol−1 K−1 larger than that of the
enantiomer, though this value is smaller than a previously
published value of 2.8 ± 0.3 J·mol−1 K−1.64,74 The heat capacity
diﬀerences of naproxen at room temperature are 1.3 ± 4.9 J·
mol−1 K−1 and within experimental uncertainty. The periodic
electronic structure calculations do show a small diﬀerence in
the heat capacities at process-relevant temperatures for
naproxen but this is independent of temperature. The separated
model ψmol gives no heat capacity diﬀerences at elevated
temperatures for any molecule. This requires a thorough
investigation of the assumptions behind current theoretical
models.
4.3. Analysis of Molecular and Lattice Vibrations from
Theoretical Models and Underlying Assumptions.
Integration of lattice vibrational modes (Supporting Informa-
tion, Tables S8−S10) yields the heat capacities, characteristic
for both molecule type and crystal packing. The separated Ψmol
model assumes the lattice modes to be suﬃciently separated in
energy and uncoupled from molecular vibrational modes (see
Supporting Information, Tables S5−S7). Hence, the separated
model ψmol inevitably predicts that ΔRS‑SCP tends to zero with
increasing temperature at about 150 K, well below ambient
temperatures (Figure 3) as the molecular modes are assumed to
be unaﬀected by the crystal structure. This does not hold for
any of the compounds (see Figure 5). Even for the “rigid”
lactide, there are some ring bending modes that are of similar
frequencies to the lattice modes. For naproxen, the low
frequency molecular modes are rotations of the propionic acid
side chain and bending of the naphthyl ring, which is nonplanar
in the enantiopure crystal structure.78 The low frequency
molecular modes of 3ClMA are rotations of the ﬂexible alpha-
hydroxy acid side chain and out-of-plane vibrations of the
chlorine atom. These very low frequency molecular modes may
couple with certain lattice modes and aﬀect the heat capacities
at low temperatures (see equations in Supporting Information,
S9−S11).
All three molecules pack so diﬀerently in the racemic and
enantiopure structures that the lowest frequency modes are
very diﬀerent in nature.
Figure 6 shows the packing diﬀerences and the lowest energy
lattice modes within the unit cells. (RS)-naproxen has a layered
structure, with only weak van-der-Waals forces between the
Figure 4. Experimental high temperature heat capacity diﬀerences,
ΔRS‑SCP, between the racemate and the enantiomer. Computed
electronic ψcrys HF-3c ΔRS‑SCV are given as dashed lines in the same
color; separated ψmol ΔRS‑SCV are zero (black straight line).
Figure 5. Comparison of the rigid-molecule k = 0 lattice frequencies of
the enantiopure and racemic crystals of lactide, 3ClMA, and naproxen
with their isolated molecule low frequency modes, to assess the validity
of the separation model ψmol. Numerical values are in the Supporting
Information (Tables S5−S10).
Figure 6. Packing of the crystals showing the lowest energy lattice
modes by vectors in atomic colors representing the amplitude and
direction of the vibrations from HF-3c k = 0 electronic structure
calculations. The red shading shows the hydrogen-bonded naproxen
layer.
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zigzag layers of hydrogen bonded dimers. The lowest frequency
lattice mode corresponds to a relative sliding of the layers with
respect to each other. In (S)-naproxen, there are hydrogen-
bonded chains which rotate relative to each other. In (RS)-
3ClMA, pairs of hydrogen-bonding layers slide relative to each
other, whereas in (S)-3ClMA the lowest mode is predominately
that of ﬂexible torsion around Φ1 (Figure 6).
The actual frequencies of these modes will be very sensitive
to the choice of computational method and its potential energy
surface; indeed, the less computationally demanding periodic
electronic structure DFTB3-D3 yields signiﬁcant diﬀerences in
low temperature heat capacities compared with the HF-3c
calculations (Supporting Information, Tables S11−S22 and
Figures S4−S5). Comparable errors result from the assumption
that the molecule is rigid and the use of an atom−atom
intermolecular potential energy surface in the separated ψmol
model for ﬂexible molecules such as naproxen and 3ClMA.
The results of ψmol and ψcrys are more consistent for the more
rigid lactide, which has more isotropic and very weak
intermolecular interactions and shows smaller heat capacity
diﬀerences. Hence, ψmol and ψcrys both fail in quantitatively
calculating the low-temperature heat capacity diﬀerences and
only give qualitative agreement with experiment (Figure 3) for
the molecules that are more typical of pharmaceuticals.
However, the error introduced by neglecting the coupling of
molecular and lattice vibrational modes and using diﬀerent
computational models is very dependent on the molecule and
crystal structure.
For the high temperature heat capacities, only the high
frequency molecular modes are relevant, as the low frequency
lattice modes have become saturated. The electronic ψcrys
calculations give diﬀerences in the high frequency modes that
lead to a small diﬀerence in heat capacities at process-relevant
temperatures for naproxen and 3ClMA but not for the lactide
(Figure 4). The electronic calculations, however, systematically
underestimate the high temperature heat capacities (Supporting
Information, Figure S11−S22) which contributes to the poor
predictions of the heat capacity diﬀerences (Figure 4).
Diﬀerences in molecular and lattice vibrations can be obtained
from the solid-state Raman spectra79 for the enantiopure and
racemic crystals (see Figure 7). For naproxen and 3ClMA, there
are detectable diﬀerences between the crystal forms in
particular at higher frequencies, i.e., the CO around 1600−
1800 cm−1 and O−H around 3000 cm−1. For lactide,
enantiopure and racemic crystals display an almost identical
Raman spectrum (Figure 7). Diﬀerences in the higher
frequency molecular modes between the racemic and
enantiopure crystals are necessary and a strong pointer for a
diﬀerence in the heat capacities at process-relevant temper-
atures.
The harmonic approximation is made in all the calculations
and is likely to be poor at relevant temperatures for most
organic crystals, as this is relatively close to their melting points
(Supporting Information, Table S3). The harmonic approx-
imation completely neglects thermal expansion of crystals,
which can diﬀer markedly in its anisotropy with the diﬀerences
in molecular packing. The anisotropic expansion of naproxen
has been estimated by a quasi-harmonic approximation
(Supporting Information, pp 29−32) and leads to an increase
in the room temperature CP (by 7 and 8 J mol
−1 K−1 for RS and
S respectively) relative to the harmonic underestimate. Using a
fully anharmonic model from Molecular Dynamics trajectories
for heat capacities would be expected to further improve the
agreement with experiment.
4.4. Comparing Thermochemical Properties for
Enantiopure and Racemic Crystals from Experiment
and Theory. Figure 8 shows the sublimation enthalpies as
estimated using the experimental and calculated thermochem-
ical properties (values in Supporting Information, Table S26).
The lattice energy is the major contribution to the absolute
values of the enthalpies of sublimation and the diﬀerences
between the racemate and enantiomer when compared to the
experimental values, where available (Figure 8). However, the
heat capacity and zero-point energy terms are still signiﬁcant
and cannot be neglected in any computational estimates of the
sublimation enthalpy.
There is a clear correlation between the diﬀerences in the
thermal corrections with the ﬂexibility and packing in racemic
and enantiopure crystal structures. The molecule and crystal-
speciﬁc phonon frequencies aﬀect the thermal corrections Hcorr
(eq 2), and the “2RT-approximation” is as inadequate for these
organic crystals as it is for those comprised of smaller molecules
(see Supporting Information, Figure S3).
For the lactide species, thermal corrections from separated
and periodic calculations are very close and the (RS-S)
diﬀerences are in excellent agreement with experimental heat
capacities corrections, although there are errors in the absolute
Figure 7. Solid-state Raman spectra of the racemic and enantiopure
crystals between 0 and 1800 cm−1 and 2700−3150 cm−1. The inset
illustrates the diﬀerent hydrogen bonding motifs, responsible for the
changes in the spectra at higher frequencies, i.e., the CO around
1600−1800 cm−1 and O−H around 3000 cm−1.
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CsP (see Supporting Information, Figure S4). However, for
naproxen and 3ClMA the diﬀerent hydrogen bonding in the
two crystals and increasing vibrational ﬂexibility lead to larger
diﬀerences in thermal corrections. The eﬀect of including the
coupling between the molecular and lattice modes is relatively
small. The magnitude, however, is still comparable to the
neglect of thermal expansion of the unit cell, which is estimated
for naproxen (Supporting Information, Figure S9) to lead to an
error of about 1 kJ mol−1 in Hcorr. The diﬀerences between the
calculated and experimental heat capacities are a signiﬁcant
source of error in ΔHsubl, up to 2.2 kJ mol−1 for (S)-3ClMA
(Supporting Information, Table S27).
4.5. Estimating the Eutectic Composition and Its
Temperature and Solvent Dependence. The eutectic
composition is the key parameter for chiral separation. It can
depend on temperature, the nature of the solvent, or both.
Figure 9 compares calculations of xeu from the thermodynamic
cycle using ΔRS‑SΔGsubl, assuming that xeu is independent of
solvent, with experimental data at 298 K.
A comparison is also made with alternative methods of
estimating the eutectic composition. Experimentally, xeu can, in
principle, be estimated using the “sublimation cycle” or the
“melt cycle” (Figure 1). In the latter, the solution free energy is
obtained via the supercooled melt (ΔGmelt) by using
experimental diﬀerences in free energies of melting ΔRS-SΔGmelt
(Supporting Information, Tables S3 and S29). The melt cycle
assumes that the free energy of mixing with the solvent (ΔGE)
is the same for both racemic and enantiopure crystals. Thus, the
melt cycle is making the same assumption as the sublimation
cycle, that the solution nonidealities of both chiral species are
the same (ΔRS‑SΔGE = 0). Results for xeu from the melt cycle
are comparable to the sublimation cycle for lactide only. For
naproxen, where both the racemic and enantiopure crystals
have almost the same melting temperature and enthalpies, the
melt cycle signiﬁcantly underestimates the Gibbs energy
diﬀerence and hence the eutectic composition.
An alternative approach to estimating xeu, concentrates on
the solvent, and uses experimentally measured solubilities of
enantiomer and racemate in a variety of solvents (Supporting
Information, Table S28) to obtain ΔGsol. If the molecular
solvation free energies are calculated using COSMO-RS73 at
inﬁnite dilution, and assuming ideal solutions, then ΔGsubl,solub,
can be recursively calculated via the sublimation cycle from
solubilities (see Supporting Information, Table S29).
A cross check on this procedure is that the estimates of
ΔRS‑SΔGsubl,solub are in good agreement with the free energies
from available vapor pressure measurements (Supporting
Information, Table S29) diﬀering only by 0.1 kJ mol−1 for
lactide and 1.4 kJ mol−1 for naproxen. Experimental solubilities
to estimate xeu (Figure 9 yellow bar) give a variation with
solvent which is of the same order of magnitude as the variation
of xeu in diﬀerent solvents at 298 K for lactide, while it is
overestimated for naproxen and underestimated for 3ClMA.
This shows that there is a signiﬁcant solvent eﬀect on the
eutectic composition at a given temperature because the
solutions of the three molecules involved are not ideal, and that
this nonideality diﬀers between the racemic and enantiopure
solutions.
The accuracy of computational predictions of xeu via the
sublimation cycle is critically dependent on the accuracy of
lattice energy diﬀerences. They systematically overestimate the
eutectic compositions, as previously found for amino acids in
water.39 The enthalpy correction, ΔHcorr, only contributes
signiﬁcantly to xeu in the case of 3ClMA, but entropic
Figure 8. (a) Absolute sublimation enthalpies, ΔHsubl, and (b)
sublimation enthalpy diﬀerences between the racemate and
enantiomer, ΔRS‑SΔHsubl, compared to experiment as colored back-
ground: (blue = lactide;65 green = naproxen;27 3ClMA decomposes),
with the plain bars corresponding to the separated model and the
striped to the electronic model. Figure 9. Eutectic compositions at 298 K. Calculated lattice energy,
enthalpy corrections, and entropy diﬀerences (white, light gray, and
gray) from ψmol and ψcrys in the sublimation cycle compared with
experiments from both cycles (green) and measured solubilities
(yellow) in diﬀerent solvents. The error bar is its variation. Maximum
(solid line) and minimum (dashed line) values of xeu in various
solvents at 298 K are also given.
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diﬀerences account for up to 4 kJ·mol−1 to ΔRS‑SΔGsubl and thus
aﬀect xeu for all molecules. Direct use of the sublimation cycle
when sublimation data are available gives very similar estimates
of xeu (Figure 9). The combination of electronic structure
calculations and experimental solubilities “exp/theory” (black
bar in Figure 9) to yield ΔRS‑SΔGsubl,exp/theory, gives the best
estimate of xeu and correlates well with experimental
sublimation free energies27,65 when using the ψcrys model.
The observed temperature dependence of xeu (Supporting
Information, Table S28) cannot be accounted for by the
calculations, but can be estimated by numerically integrating
the measured heat capacity diﬀerences between 298 and 318 K.
There is a small temperature eﬀect on the Gibbs free energy of
sublimation diﬀerences ΔT1‑T2ΔRS‑SΔGsubl which slightly shifts
the eutectic composition: for lactide and naproxen, xeu
decreases by −0.4 and −0.9 mol % and increases by 0.6 mol
% for 3ClMA. In the experiment, these values are dependent on
solvent and vary between 0 and −3.0 for lactide and 0 and 1.3
for 3ClMA. For naproxen, the solvent independent shift is
slightly underestimated (−1.2 mol %). Thus, the nature of the
solvent not only aﬀects the eutectic composition at a given
temperature but may also promote or prevent shifts of xeu with
temperature. There are examples in the literature, where xeu is
temperature dependent in one solvent and independent in
another.7 Unlike 3ClMA, the eutectic composition of mandelic
acid is constant at xeu = 69% and shows no variation in diﬀerent
solvents and over a large temperature range.4 This is surprising
as mandelic acid displays a diﬀerence in heat capacity between
the racemic and enantiopure crystal which is dependent on
temperature.31 This has to be explained by a cancellation of
diﬀerent eﬀects. We have to conclude that the eutectic
composition and its temperature dependence Δxeu(T) is not
a mere solid state property. Accurate predictions will have to
consider the diﬀerences in solvation free energies for the
racemic and enantiopure solutions. This implies consideration
of the nonideality of the solution in terms of the speciﬁc
molecule, its solvent, as well as solute−solute interactions.
5. DISCUSSION
5.1. Diﬀerences in Gibbs Free Energies from
Thermodynamic Cycles. Two thermodynamic cycles, the
“melt” and the “sublimation” cycle enable the eutectic shift xeu
to be estimated from the thermodynamic properties of the
enantiopure and racemic compound. We have shown that the
sublimation cycle is competitive in accuracy with the traditional
melt cycle and has the advantage that the required solid-state
thermodynamic quantities can, in principle, be estimated
computationally with high accuracy.80 However, our detailed
comparison for three diverse systems shows that there is a
strong dependence of the thermochemical properties on the
intermolecular interactions and molecular ﬂexibility diﬀerences
in the racemic and enantiopure crystals. Heat capacity
diﬀerences at ambient temperature for the enantiopure and
racemic forms of pharmaceuticals could provide a suﬃcient
temperature-dependent shift in the eutectic composition to
enable a resolution of enantiomers by a two-step crystallization
process. A necessary requirement for this is a diﬀerence in the
high frequency molecular vibrational modes between the two
crystals, which should be apparent in the Raman or infrared
spectrum, and is likely to be linked to changes in hydrogen
bonding interactions. Many other assumptions frequently used
when modeling organic solid state thermodynamics do not
hold. Phonon modes, which are dependent on crystal packing,
lead to thermal expansion at ﬁnite temperature and solid state
heat capacities which may diﬀer between the racemic and
enantiopure crystals. The often made assumption that lattice
energies and sublimation enthalpies diﬀer by 2RT, so that the
molecular motion in crystals can be neglected, is over-
simplifying the thermodynamics of industrially important
organic crystals. Our results also conﬁrm that assuming the
solvation energy is the same for the enantiopure and racemic
compound is not always realistic enough for the prediction of
eutectic shifts.81
5.2. Computational Challenges. The separation of
enantiomers poses a challenge to modern computational
methods. When lattice energy calculations show that the
racemic crystal is much more stable than the enantiopure, the
enantiomers in the racemate cannot be separated, but a simple
thermodynamically controlled one-step crystallization will
remove the racemate leaving an enantiopure solution.21 In
the case of small lattice energy diﬀerences, separation of
enantiomers by a two-step crystallization process may be
exploitable. It is very rare for the molecular chirality to provide
a strong preference for a chiral packing in all three directions,
such that an enantiopure crystal is signiﬁcantly more stable than
any racemic structure.82
Current state-of-the-art electronic structure methods typi-
cally have lattice energy errors in the range of 3−7 kJ·mol−1 for
crystals of small organic molecules.83,84 When lattice energy
diﬀerences are small enough for chiral separation to be feasible,
<4 kJ·mol−1, the diﬀerences in thermodynamic contributions
that arise from the ﬁnite temperature eﬀects become signiﬁcant.
The degree of cancellation between zero-point lattice energy,
thermal corrections, and entropy terms will depend on the
speciﬁc crystal structures. When the molecule is rigid and the
intermolecular interactions are not aﬀecting the molecular
structure or vibrations, there is only a diﬀerence in heat
capacities at low temperatures. However, for ﬂexible molecules,
particularly if there is a diﬀerence in the hydrogen bonding and
anisotropy of thermal expansion, relative heat capacities at
ambient temperatures will require periodic electronic structure
calculations of lattice and molecular vibrations plus inclusion of
thermal expansion eﬀects. When accurate harmonic modes can
be calculated, these are likely to underestimate heat capacities at
process relevant temperatures because of the neglect of thermal
expansion. Even the quasi-harmonic approximation may not be
adequate for absolute heat capacities, as shown by a comparison
of phonon modes by lattice and molecular dynamics.85 Flexible
pharmaceuticals can have very anharmonic intramolecular
modes, such as methyl rotations and large amplitude phenyl
librations. While there is a clear path to improving the
calculation of the solid-state thermodynamics in the sub-
limation cycle, it is less clear how the observed eﬀects of the
solvent on the eutectic shift can be predicted without explicit
solvent molecular dynamics as nonidealities of mixtures need to
be considered. Thus, a reliable computational prediction of the
eutectic shift and its dependence on temperature and solvent
will require great accuracy in all contributions to the
thermodynamic cycles.86
5.3. Indications of Eutectic Shifts. Resolution of
enantiomers by selective crystallization can be supported by
theoretical approaches. High quality calculated lattice energy
diﬀerences can determine when crystal energies are too large
for a separation by crystallization to be possible. Phonon
calculations can show whether the diﬀerences in crystal
structures results are likely to lead to signiﬁcant heat capacity
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diﬀerences. A diﬀerence in the higher frequency “molecular
modes” in the Raman spectra of the two crystals is a strong
indicator of a shift in eutectic composition exploitable in a
process-relevant temperature range. The fundamental exper-
imental choice of solvent could be assisted by looking for
changes in the free energies of sublimation derived from
experimental solubilities correcting for the computed molecular
solvation energy. This might replace some of the tedious
determinations of many ternary phase diagrams. However, the
prediction of eutectic shifts may still be limited by the
assumption of equilibrium thermodynamic models to describe
crystallization, which appears questionable for some sys-
tems.29,87
6. CONCLUSION
We have compared computed and experimental thermody-
namic data for three pairs of enantiopure and racemic crystals
of prototypical organic molecules, which are more representa-
tive of pharmaceuticals than crystals composed of atoms or
small, rigid molecules. The sublimation cycle oﬀers consid-
erable promise as a method of evaluating the possibilities for
chiral resolution by crystallization, which can be done by a
combination of calculations and experimental data. Some
systematic errors in both experimental procedures and
theoretical assumptions have widely been expected to cancel
in the diﬀerences between enantiopure and racemic crystals, or
in estimating derived thermodynamic quantities. However, the
degree of cancellation has been shown to be very dependent on
the molecule, its functional groups, and their ﬂexibility and how
this is manifested in diﬀerences in the solid-state structures and
solution behavior. Reliably predicting the eutectic composition
is still a major challenge to computational modeling and the
rational exploitation of crystallization processes. However,
molecular-level insights into the diﬀerences between speciﬁc
enantiopure and racemic structures can help assess the
feasibility of designing processes to separate enantiomers.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.cgd.7b00582.
Additional information regarding computational details,
materials and methods and experimental measurements
of heat capacities and solubilities (PDF)
■ AUTHOR INFORMATION
Corresponding Authors
*(M.S.) E-mail: matthias.stein@mpi.magdeburg.mpg.de.
*(S.L.P.) E-mail: s.l.price@ucl.ac.uk.
ORCID
Andreas Seidel-Morgenstern: 0000-0001-7658-7643
Matthias Stein: 0000-0001-7793-0052
Sarah L. Price: 0000-0002-1230-7427
Author Contributions
#H.B. and R.K.H. contributed equally.
Funding
Max Planck Society for the Advancement of Science, ESPRC
EP/K039229/1 and the EU COST Action CM1402.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
R.K.H. is grateful for a UCL-MPS Impact Ph.D. Fellowship.
J.G.B. acknowledges support by the Humboldt foundation
within the Feodor-Lynen program. This work was also
supported in part by the Max Planck Society for the
Advancement of Science, ESPRC EP/K039229/1 and the EU
COST Action CM1402 “Crystallize”. We thank Prof. K. Refson
for discussions and help with preliminary work on DFT-D
calculations which were performed on ARCHER, via our
membership of the UK’s HPC Materials Chemistry Con-
sortium, funded by EPSRC (EP/L000202). Dr. N. van Well
and Prof. C. Krellner from the Goethe University Frankfurt are
acknowledged for support of the low temperature heat capacity
measurements.
■ REFERENCES
(1) Nguyen, L. A.; He, H.; Pham-Huy, C. Chiral Drugs: An
Overview. Int. J. Biomed. Sci. 2006, 2 (2), 85−100.
(2) Development of New Stereoisomeric Drugs; U.S. Food and Drug
Administration, 1992.
(3) Ulrich, E. M.; Morrison, C. N.; Goldsmith, M. R.; Foreman, W.
T. Chiral Pesticides: Identiﬁcation, Description, and Environmental
Implications. In Reviews of Environmental Contamination and
Toxicology; Whitacre, D. D. M., Ed.; Springer: New York, 2012.
(4) Lorenz, H.; Seidel-Morgenstern, A. Processes To Separate
Enantiomers. Angew. Chem., Int. Ed. 2014, 53 (5), 1218−1250.
(5) Otero-de-la-Roza, A.; Hein, J. E.; Johnson, E. R. Reevaluating the
Stability and Prevalence of Conglomerates: Implications for
Preferential Crystallization. Cryst. Growth Des. 2016, 16 (10), 6055−
6059.
(6) Klussmann, M.; White, A. J. R.; Armstrong, A.; Blackmond, D. G.
Rationalization and prediction of solution enantiomeric excess in
ternary phase systems. Angew. Chem., Int. Ed. 2006, 45 (47), 7985−
7989.
(7) Lorenz, H.; Le Minh, T.; Kaemmerer, H.; Buchholz, H.; Seidel-
Morgenstern, A. Exploitation of shifts of eutectic compositions in
crystallization-based enantioseparation. Chem. Eng. Res. Des. 2013, 91
(10), 1890−1902.
(8) Grant, D. J. W.; Higuchi, T. Solubility Behavior of Organic
Compounds; John Wiley and Sons: New York, 1990.
(9) Palmer, D. S.; Llinas̀, A.; Morao, I.; Day, G. M.; Goodman, J. M.;
Glen, R. C.; Mitchell, J. B. O. Predicting Intrinsic Aqueous Solubility
by a Thermodynamic Cycle.Mol. Pharmaceutics 2008, 5 (2), 266−279.
(10) Chu, K. A.; Yalkowsky, S. H. Predicting Aqueous Solubility: The
Role of Crystallinity. Curr. Drug Metab. 2009, 10 (10), 1184−1191.
(11) Yalkowsky, S. H.; Wu, M. Estimation of the Ideal Solubility
(Crystal-Liquid Fugacity Ratio) of Organic Compounds. J. Pharm. Sci.
2010, 99 (3), 1100−1106.
(12) Ran, Y. Q.; Jain, N.; Yalkowsky, S. H. Prediction of aqueous
solubility of organic compounds by the general solubility equation
(GSE). J. Chem. Inf Comp Sci. 2001, 41 (5), 1208−1217.
(13) Hughes, L. D.; Palmer, D. S.; Nigsch, F.; Mitchell, J. B. O. Why
Are Some Properties More Difficult To Predict than Others? A Study
of QSPR Models of Solubility, Melting Point, and Log P. J. Chem. Inf.
Model. 2008, 48 (1), 220−232.
(14) Diedrichs, A.; Gmehling, J. Solubility Calculation of Active
Pharmaceutical Ingredients in Alkanes, Alcohols, Water and their
Mixtures Using Various Activity Coefficient Models. Ind. Eng. Chem.
Res. 2011, 50 (3), 1757−1769.
(15) Tetko, I. V.; Sushko, Y.; Novotarskyi, S.; Patiny, L.; Kondratov,
I.; Petrenko, A. E.; Charochkina, L.; Asiri, A. M. How Accurately Can
We Predict the Melting Points of Drug-like Compounds? J. Chem. Inf.
Model. 2014, 54 (12), 3320−3329.
(16) Gharagheizi, F.; Gohar, M. R. S.; Vayeghan, M. G. A quantitative
structure−property relationship for determination of enthalpy of
fusion of pure compounds. J. Therm. Anal. Calorim. 2012, 109 (1),
501−506.
Crystal Growth & Design Article
DOI: 10.1021/acs.cgd.7b00582
Cryst. Growth Des. 2017, 17, 4676−4686
4684
(17) Klamt, A.; Eckert, F.; Hornig, M.; Beck, M. E.; Bürger, T.
Prediction of aqueous solubility of drugs and pesticides with COSMO-
RS. J. Comput. Chem. 2002, 23 (2), 275−281.
(18) Ruether, F.; Sadowski, G. Modeling the Solubility of
Pharmaceuticals in Pure Solvents and Solvent Mixtures for Drug
Process Design. J. Pharm. Sci. 2009, 98 (11), 4205−4215.
(19) McDonagh, J. L.; Nath, N.; De Ferrari, L.; van Mourik, T.;
Mitchell, J. B. O. Uniting Cheminformatics and Chemical Theory To
Predict the Intrinsic Aqueous Solubility of Crystalline Druglike
Molecules. J. Chem. Inf. Model. 2014, 54 (3), 844−856.
(20) McDonagh, J. L.; Palmer, D. S.; Mourik, T. v.; Mitchell, J. B. O.
Are the Sublimation Thermodynamics of Organic Molecules
Predictable? J. Chem. Inf. Model. 2016, 56 (11), 2162−2179.
(21) Jaques, J.; Collet, A.; Wilen, S. Enantiomers, Racemates, and
Resolutions; Wiley and Sons Inc.: New York, 1981.
(22) Toda, F. Enantiomer Separation: Fundamentals and Practical
Methods; Kluwer Academic, Dordrecht, 2007.
(23) Klimm, D. Phase Equilibria. In Handbook of Crystal Growth, 2nd
ed.; Nishinaga, T., Ed.; Elsevier: Boston, 2015; Vol. A, pp 85−136.
(24) van Hummel, G. J.; Harkema, S.; Kohn, F. E.; Feijen, J.
Structure of 3,6-dimethyl-1,4-dioxane-2,5-dione [D-,D-(L-,L-)lactide].
Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. 1982, 38 (5),
1679−1681.
(25) Belen’kaya, B. G.; Bel’skii, V. K.; Dement’ev, A. I.; Sakharova, V.
I.; Chernikova, N. Y. Crystal and Molecular Structures of Glycolide
and Lactide: Association through CH···O Hydrogen Bonds.
Crystallogr. Rep. 1997, 42 (3), 449−452.
(26) Auras, R.; Lim, L.-T.; Selke, S.; Tsuji, H. Poly(Lactid Acid) −
Synthesis, Structures, Properties, Processing and Application; John Wiley
& Sons: Hoboken, NJ, 2010.
(27) Buchholz, H.; Emel’yanenko, V. N.; Lorenz, H.; Verevkin, S. P.
An Examination of the Phase Transition Thermodynamics of (S)- and
(RS)-Naproxen as a Basis for the Design of Enantioselective
Crystallization Processes. J. Pharm. Sci. 2016, 105 (5), 1676−1683.
(28) Braun, D. E.; Ardid-Candel, M.; D’Oria, E.; Karamertzanis, P.
G.; Arlin, J. B.; Florence, A. J.; Jones, A. G.; Price, S. L. Racemic
Naproxen: A Multidisciplinary Structural and Thermodynamic
Comparison with the Enantiopure Form. Cryst. Growth Des. 2011,
11 (12), 5659−5669.
(29) Hylton, R. K.; Tizzard, G. J.; Threlfall, T. L.; Ellis, A. L.; Coles,
S. J.; Seaton, C. C.; Schulze, E.; Lorenz, H.; Seidel-Morgenstern, A.;
Stein, M.; Price, S. L. Are the Crystal Structures of Enantiopure and
Racemic Mandelic Acids Determined by Kinetics or Thermody-
namics? J. Am. Chem. Soc. 2015, 137 (34), 11095−11104.
(30) Le Minh, T.; Von Langermann, J.; Lorenz, H.; Seidel-
Morgenstern, A. Enantiomeric 3-Chloromandelic Acid System: Binary
Melting Point Phase Diagram, Ternary Solubility Phase Diagrams and
Polymorphism. J. Pharm. Sci. 2010, 99 (9), 4084−4095.
(31) Leclercq, M.; Collet, A.; Jacques, J. Etude des Melanges
d’Antipodes Optiques - XII. Tetrahedron 1976, 32, 821−828.
(32) Paukov, I. E.; Kovalevskaya, Y. A.; Boldyreva, E. V. Low-
temperature heat capacity of L- and DL-phenylglycines. J. Therm. Anal.
Calorim. 2012, 108 (3), 1311−1316.
(33) Paukov, I. E.; Kovalevskaya, Y. A.; Boldyreva, E. V. Low-
temperature thermodynamic properties of L- and DL-valines. J. Therm.
Anal. Calorim. 2013, 111 (1), 905−910.
(34) Drebushchak, V. A.; Kovalevskaya, Y. A.; Paukov, I. E.;
Boldyreva, E. V. Heat capacity of D- and DL-serine in a temperature
range of 5.5 to 300 K. J. Therm. Anal. Calorim. 2007, 89 (2), 649−654.
(35) Makhatadze, G. I. Heat capacities of amino acids, peptides and
proteins. Biophys. Chem. 1998, 71 (2−3), 133−156.
(36) Paukov, I. E.; Kovalevskaya, Y. A.; Boldyreva, E. V. Low-
temperature thermodynamic properties of L-cysteine. J. Therm. Anal.
Calorim. 2008, 93 (2), 423−428.
(37) Paukov, I. E.; Kovalevskaya, Y. A.; Boldyreva, E. V. Low-
temperature thermodynamic properties of dl-cysteine. J. Therm. Anal.
Calorim. 2010, 100 (1), 295−301.
(38) Wang, Y. L.; LoBrutto, R.; Wenslow, R. W.; Santos, I. Eutectic
composition of a chiral mixture containing a racemic compound. Org.
Process Res. Dev. 2005, 9 (5), 670−676.
(39) Otero-de-la-Roza, A.; Cao, B. H.; Price, I. K.; Hein, J. E.;
Johnson, E. R. Predicting the Relative Solubilities of Racemic and
Enantiopure Crystals by Density-Functional Theory. Angew. Chem.,
Int. Ed. 2014, 53 (30), 7879−7882.
(40) Dunitz, J. D.; Gavezzotti, A. Molecular recognition in organic
crystals: Directed intermolecular bonds or nonlocalized bonding?
Angew. Chem., Int. Ed. 2005, 44 (12), 1766−1787.
(41) Dunitz, J. D.; Gavezzotti, A. How molecules stick together in
organic crystals: weak intermolecular interactions. Chem. Soc. Rev.
2009, 38 (9), 2622−2633.
(42) Erdemir, D.; Lee, A. Y.; Myerson, A. S. Nucleation of Crystals
from Solution: Classical and Two-Step Models. Acc. Chem. Res. 2009,
42 (5), 621−629.
(43) Nangia, A. Conformational polymorphism in organic crystals.
Acc. Chem. Res. 2008, 41 (5), 595−604.
(44) Cruz-Cabeza, A. J.; Bernstein, J. Conformational Polymorphism.
Chem. Rev. 2014, 114 (4), 2170−2191.
(45) Nyman, J.; Day, G. M. Static and lattice vibrational energy
differences between polymorphs. CrystEngComm 2015, 17 (28),
5154−5165.
(46) Day, G. M.; Price, S. L.; Leslie, M. Atomistic calculations of
phonon frequencies and thermodynamic quantities for crystals of rigid
organic molecules. J. Phys. Chem. B 2003, 107 (39), 10919−10933.
(47) Abdulla, M.; Refson, K.; Friend, R. H.; Haynes, P. D. A first-
principles study of the vibrational properties of crystalline tetracene
under pressure. J. Phys.: Condens. Matter 2015, 27 (37), 375402.
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